Pfizer Moves CNS And Cardio-Metabolic Research To Cambridge, Mass., Promotes Cross-Talk With Local Scientists
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer has relocated its neuroscience and cardiovascular medicine research groups from Groton, Conn., to Cambridge, Mass. Currently in temporary labs, the research will move into permanent space in 2013. The goal is to foster cross-talk and collaboration with local scientists and with Pfizer’s CTI program in nearby Boston.